HomeCategory

Dihydrotestosterone Archives - Dr. Zaar

February 4, 2024

Case Study:  Introduction: Polycystic Ovary Syndrome (PCOS) affects millions of women globally, presenting with hormonal imbalances, irregular menstrual cycles, and fertility challenges. While numerous treatment options exist, personalized approaches are crucial. This case study explores the potential of DHEA supplementation in managing PCOS symptoms, focusing on the experience of Sarah, a 32-year-old woman struggling with...

February 4, 2024

Case Study:  Introduction This case study examines the treatment of Benign Prostatic Hyperplasia (BPH) in an elderly male patient, with a focus on the inhibition of dihydrotestosterone (DHT) as a therapeutic strategy. Patient Background Profile: 62-year-old male with a history of urinary symptoms indicative of BPH. Medical History: Progressive symptoms over the last two years,...

February 4, 2024

Case Study:  Introduction This case study explores the management of male pattern baldness in an adult male, focusing on the role of dihydrotestosterone (DHT) inhibition as a therapeutic strategy. Patient Background Profile: 45-year-old male experiencing progressive hair thinning and receding hairline. Medical History: No significant health issues; family history of male pattern baldness. Initial Assessment...

February 4, 2024

Case Study:  Introduction This case study examines the management of hormonal acne in a young adult female, with an emphasis on inhibiting dihydrotestosterone (DHT) as a key hormonal contributor to acne development. Patient Background Profile: 24-year-old female experiencing persistent acne outbreaks, predominantly around the chin and jawline. Medical History: No significant medical conditions; regular menstrual...

February 4, 2024

“Exploring DHT’s Contribution to Polycystic Ovary Syndrome (PCOS) and Androgen Excess” Polycystic Ovary Syndrome (PCOS) is a complex endocrine disorder that affects millions of women worldwide. Among its various contributing factors, the role of dihydrotestosterone (DHT) and androgen excess has gained significant attention in recent research. This article delves into the intricate relationship between DHT,...

February 4, 2024

Case Study:  Introduction This case study presents the management of a 28-year-old woman diagnosed with Polycystic Ovary Syndrome (PCOS) and androgen excess, with a focus on inhibiting dihydrotestosterone (DHT) to alleviate symptoms. Patient Background Profile: 28-year-old female experiencing irregular menstrual cycles, hirsutism, acne, and obesity. Medical History: PCOS diagnosis based on ultrasound and hormonal assessments....

February 4, 2024

Case Study:  Introduction This case study examines the successful management of hirsutism in a 32-year-old female patient, with a primary emphasis on inhibiting dihydrotestosterone (DHT) to alleviate symptoms and improve her quality of life. Patient Background Profile: 32-year-old woman experiencing excessive facial and body hair growth, affecting self-esteem and confidence. Medical History: No underlying medical...

February 4, 2024

Case Study:  Introduction This case study explores the management of prostate cancer in a 65-year-old male patient, focusing on the use of hormonal therapies targeting dihydrotestosterone (DHT) to control disease progression and improve the patient’s quality of life. Patient Background Profile: 65-year-old male with a history of prostate cancer. Medical History: Diagnosed with localized prostate...

February 4, 2024

Case Study: Introduction This case study examines the management of Androgen Insensitivity Syndrome (AIS) in a 20-year-old individual with a genetic mutation leading to insensitivity to dihydrotestosterone (DHT), emphasizing the hormonal and psychological aspects of care. Patient Background Profile: 20-year-old individual with female external genitalia and a genetic mutation causing AIS. Medical History: Diagnosed with...

February 4, 2024

Case Study:  Introduction This case study explores the journey of Alex, a 26-year-old individual assigned female at birth (AFAB) who sought gender-affirming care, including the administration of dihydrotestosterone (DHT), to transition to a male gender identity. The study highlights the process of hormone therapy, its effects, and the impact on Alex’s well-being. Patient Background Profile:...

© 2023. All rights reserved.